2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Small Cell Lung Carcinoma
11
Lung Neoplasms
5
Breast Neoplasms
2
Urinary Bladder Neoplasms
1
Thymus Neoplasms
1
Thymoma
1
Small Cell Lung Cancer Extensive Stage
1
Sarcoma
1
Neoplasms
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Advanced Solid Tumors
1
Interventions
selinexor
1
sacituzumab govitecan
1
amrubicin
1
Topotecan
1
PM 01183
1
Drug Therapy
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
×
amrubicin
×
Clear all
NCT06801834
2026-05-20
EVOKE-SCLC-04
Gilead Sciences
Phase 3
Recruiting
695 enrolled